151 related articles for article (PubMed ID: 27741122)
1. Possibly propylthiouracil-induced antineutrophilic cytoplasmic antibody-associated vasculitis manifested as blood coagulation disorders: A case report.
Yi XY; Wang Y; Li QF; Li R; Yang SM; Zhou GQ; Wang ZH
Medicine (Baltimore); 2016 Oct; 95(41):e5068. PubMed ID: 27741122
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
3. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
4. A fatal case of propylthiouracil-induced ANCA-positive vasculitis.
Batchelor N; Holley A
MedGenMed; 2006 Oct; 8(4):10. PubMed ID: 17415292
[TBL] [Abstract][Full Text] [Related]
5. [Antineutrophil cytoplasmic autoantibody positive vasculitis induced by propylthiouracil: a case report].
Zhang JJ; Chen YN; Xiao HJ; Liu JC; Yang JY
Zhonghua Er Ke Za Zhi; 2004 May; 42(5):379-82. PubMed ID: 15189700
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).
Nakamori Y; Tominaga T; Inoue Y; Shinohara K
Intern Med; 2003 Jun; 42(6):529-33. PubMed ID: 12857055
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
Ye H; Gao Y; Guo XH; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
[TBL] [Abstract][Full Text] [Related]
10. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
[TBL] [Abstract][Full Text] [Related]
12. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil induced ANCA-associated vasculitis in a 14-year-old girl.
Schamp V; Verfaillie C; Bonroy C; Vande Walle J; Raes A; Dehoorne J
Acta Clin Belg; 2015 Apr; 70(2):127-9. PubMed ID: 25937486
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Chen M; Gao Y; Guo XH; Zhao MH
Nat Rev Nephrol; 2012 Jun; 8(8):476-83. PubMed ID: 22664738
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis--a case report.
Wang LH; Tsai MJ; Tsai WY; Lee JS; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):642-5. PubMed ID: 10969508
[TBL] [Abstract][Full Text] [Related]
18. Concomitant drug- and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA.
Kontic M; Radovanovic S; Nikolic M; Bonaci-Nikolic B
Med Princ Pract; 2012; 21(5):488-91. PubMed ID: 22538212
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease.
Aoki Y; Kitazawa K; Kobayashi H
Paediatr Int Child Health; 2019 May; 39(2):142-145. PubMed ID: 29457989
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.
Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A
Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
